- Lumenis (NASDAQ:LMNS) has raised $75M in its Nasdaq by selling 6.25M shares at $12 each, well below the range of $15-17.
- Lumenis develops laser-based systems used in surgical, ophthalmic and aesthetic procedures.
- SA author Don Dion rated Lumenis at a "Buy" before the pricing of the shares. "LMNS has recorded an impressive six consecutive quarters of revenue and profitability growth, and now seems to be hitting its stride with a rapidly expanding Asia-Pacific market," Dion writes.
- See also IPOdesktop's preview.
- ETF: IPO